2

2invest

Africa, Beau Vallon, Seychelles, Mahé

Description

An online broker

Investor Profile

2invest has made 2 investments, with 0 in the past 12 months and 0% as lead.

Stage Focus

  • Series B (50%)
  • Series A (50%)

Country Focus

  • United Kingdom (100%)

Industry Focus

  • Biotechnology
  • Simulation
  • Therapeutics
  • Translation Service
  • Health Care
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does 2invest frequently co-invest with?

Vulpes Investment Management Pte Ltd
Asia, Central Region, Singapore, Singapore
Co-Investments: 1
Claris Ventures
Europe, Piemonte, Italy, Torino
Co-Investments: 1
Sixth Element Capital
Europe, Buckinghamshire, United Kingdom, Berkhamsted
Co-Investments: 1
3B Future Health Fund
Europe, Bayern, Germany, Monaco
Co-Investments: 1
Astellas Venture Management
North America, California, United States, Menlo Park
Co-Investments: 1
British Business Bank
Europe, Sheffield, United Kingdom, Sheffield
Co-Investments: 1
Sofinnova Partners
Europe, Ile-de-France, France, Paris
Co-Investments: 1
Epidarex Capital
North America, Maryland, United States, Bethesda
Co-Investments: 1

What are some of recent deals done by 2invest?

Leucid Bio

London, England, United Kingdom

Leucid is progressing novel cart therapies that produce a better and more durable response.

BiotechnologyHealth Care
Series AOct 21, 2021
Amount Raised: $15,860,166
NeoPhore

Cambridge, Cambridgeshire, United Kingdom

NeoPhore is a provider of novel small molecule therapies intended to treat cancer through stimulation of the immune system.

BiotechnologySimulationTherapeuticsTranslation Service
Series BMar 9, 2021
Amount Raised: $21,108,883